| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/25/2007 | WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof |
| 10/25/2007 | WO2007119590A1 Wheat-derived anti-hypertensive composition |
| 10/25/2007 | WO2007119367A1 Composition containing biopterin and method for using the same |
| 10/25/2007 | WO2007118984A1 Use of (s)-roscovitine for manufacturing a medicine |
| 10/25/2007 | WO2007118967A1 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine |
| 10/25/2007 | WO2007118830A1 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 10/25/2007 | WO2007118680A2 Remedies for ischemia |
| 10/25/2007 | WO2007118602A1 Compounds for treating pulmonary hypertension |
| 10/25/2007 | WO2007118363A1 A chinese medicine composition and preparation method and use thereof |
| 10/25/2007 | WO2007106467A3 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy) phenylacetyl]thiophene-3-sulfonamide, sodium salt |
| 10/25/2007 | WO2007103160A3 Stearidonic acid for improving cardiovascular health |
| 10/25/2007 | WO2007098352A3 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 10/25/2007 | WO2007090095A3 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics |
| 10/25/2007 | WO2007041112A3 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 10/25/2007 | WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use |
| 10/25/2007 | US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes) |
| 10/25/2007 | US20070249729 Method of Treating Elevated Plasma Homocysteine Levels in Esrd Patients |
| 10/25/2007 | US20070249720 Thiourea Derivative-Containing Pharmaceutical Composition Having Improved Solubility and Bioavailability |
| 10/25/2007 | US20070249719 Compounds for the treatment of metabolic disorders |
| 10/25/2007 | US20070249703 (Hydroxyphenyl)-1H-Indole-3-Carbaldehyde Oxime Derivatives As Estrogenic Agents |
| 10/25/2007 | US20070249700 Pyrazolone Compounds Useful for Treatment of Cerebrovascular Disorders Associated with Ischemic Stroke |
| 10/25/2007 | US20070249696 Compounds for the treatment of metabolic disorders |
| 10/25/2007 | US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications |
| 10/25/2007 | US20070249663 Corticotropin-Releasing Factor (CRF) receptor antagonist as therapeutic agent for depression, depressive symptom, or irritable bowel syndrome |
| 10/25/2007 | US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 10/25/2007 | US20070249653 Tetracyclic benzamide derivatives and methods of use thereof |
| 10/25/2007 | US20070249650 isolating and purifying quaternary ammonium alkaloid species from medicinal plant of Yan Huang Lian (Corydalis saxicola Bounting) through solvent extraction, crystallization and recrystallization; for treating viral hepatitis, hepatic injury, influenza, AIDS, tumors or arrhythmia |
| 10/25/2007 | US20070249641 Adenosine a3 receptor modulators |
| 10/25/2007 | US20070249638 Derivatives of triazoly-imidazopyridine and of the triazolypurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 10/25/2007 | US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases |
| 10/25/2007 | US20070249605 such as methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetate |
| 10/25/2007 | US20070249555 Use of Atp Analogues for Treatment of Cardiovascular Diseases |
| 10/25/2007 | US20070249541 Combined use of enzyme inhibitors and of pharmaceutical compositions thereof |
| 10/25/2007 | US20070248676 Use of nitric oxide adducts |
| 10/25/2007 | US20070248617 Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides |
| 10/25/2007 | US20070248598 Recombinant anti-VLA4 antibody molecules |
| 10/25/2007 | US20070248597 Methods of decreasing vascular calcification using IL-1 inhibitors |
| 10/25/2007 | US20070248577 Methods and compositions for administering stem cells |
| 10/25/2007 | CA2652826A1 A composition comprising extracts of radix ginseng, folium ginkgo, stigma croci and glycine max and use thereof for treating ischemic cerebrovascular disease |
| 10/25/2007 | CA2649735A1 Activating agent for peroxisome proliferator activated receptor .delta. |
| 10/25/2007 | CA2649710A1 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 10/25/2007 | CA2649287A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands |
| 10/25/2007 | CA2649175A1 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 10/25/2007 | CA2649173A1 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 10/25/2007 | CA2649150A1 Thioxanthine derivatives and their use as inhibitors of mpo |
| 10/25/2007 | CA2648748A1 Nitrogen-containing heterocyclic compound |
| 10/25/2007 | CA2648642A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 10/25/2007 | CA2647705A1 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| 10/25/2007 | CA2647694A1 Use of (s)-roscovitine for manufacturing a medicine |
| 10/25/2007 | CA2647501A1 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine |
| 10/24/2007 | EP1847614A1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virions (raav virions), and method and use for treating amino acid metabolic disorders using such raav virions |
| 10/24/2007 | EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 10/24/2007 | EP1847530A1 Diamine derivative |
| 10/24/2007 | EP1847271A2 Water-absorbent polymers and their use as a medicament |
| 10/24/2007 | EP1847266A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 10/24/2007 | EP1847264A1 Patch |
| 10/24/2007 | EP1847244A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 10/24/2007 | EP1846452A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 10/24/2007 | EP1846407A1 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide as inhibitors of renin for the treatment of hypertension. |
| 10/24/2007 | EP1846402A1 3-amino-pyrazolo[3,4b]pyridines used as inhibitors of protein tyrosine kinases for treating angiogenic, hyperproliferative or neurodegenerative diseases |
| 10/24/2007 | EP1846391A2 Raf inhibitor compounds and methods |
| 10/24/2007 | EP1846380A1 Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use |
| 10/24/2007 | EP1846374A1 Cinnamate salts of a beta-2 adrenergic agonist |
| 10/24/2007 | EP1846021A2 Novel method for treating chronic severe heart failure by using insulin-like growth factor-1 (igf-1) |
| 10/24/2007 | EP1846019A2 Method for treating cardiovascular disease |
| 10/24/2007 | EP1846017A1 Angiotensin i derivatives |
| 10/24/2007 | EP1846016A2 Methods of increasing cerebral blood flow |
| 10/24/2007 | EP1846014A2 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally senstive transmembrane peptide |
| 10/24/2007 | EP1845971A1 A method of treating cellular damage |
| 10/24/2007 | EP1845961A1 Prevention and treatment of thromboembolic disorders |
| 10/24/2007 | EP1845951A2 Embolization using poly-4-hydroxybutyrate particles |
| 10/24/2007 | EP1658081B1 Immunosuppressive effects of pteridine derivatives |
| 10/24/2007 | EP1606307B1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors |
| 10/24/2007 | EP1471899B1 Use of ambroxol in the treatment of chronic pain |
| 10/24/2007 | EP1365771B1 Method of treating certain eye diseases |
| 10/24/2007 | EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 10/24/2007 | EP1207860B1 Controlled release pellet formulation |
| 10/24/2007 | EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase |
| 10/24/2007 | CN101060840A Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and ATP levels in cells |
| 10/24/2007 | CN101058823A Method of preparing cytidine disodium triphosphate and application |
| 10/24/2007 | CN101058568A Novel medicinal salt for cinepazide and preparation method thereof |
| 10/24/2007 | CN101058567A Novel pharmacology acceptable salt for cinepazide |
| 10/24/2007 | CN101058565A Stable cinepazide water-soluble salt |
| 10/24/2007 | CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 10/24/2007 | CN101058556A Diphenylacetidinon derivatives for treatment of disordered lipid metabolism, method of production thereof(variants), pharmaceutical composition |
| 10/24/2007 | CN101057965A Compound traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular disease |
| 10/24/2007 | CN101057954A Traditional Chinese medicine compound for treating transient ischemic attack and its preparation method |
| 10/24/2007 | CN101057949A Traditional Chinese medicine one-step preparation for treating coronary heart disease |
| 10/24/2007 | CN101057946A Traditional Chinese medicine for treating heart disease |
| 10/24/2007 | CN101057940A Apoplexy recover pills |
| 10/24/2007 | CN101057936A Fat-smoothing capsule and its preparation method |
| 10/24/2007 | CN101057934A Medicine for treating heart failure |
| 10/24/2007 | CN101057929A Traditional Chinese medicine for warming and washing for piles |
| 10/24/2007 | CN101057908A Heart and brain health dispersion tablet and its preparation method |
| 10/24/2007 | CN101057905A Microwave extraction method for cordate houttuynia total flavones |
| 10/24/2007 | CN101057890A Traditional Chinese medicinal composition for treating coronary heart disease and its preparation method, preparations and its application |
| 10/24/2007 | CN101057882A Medicinal composition for treating coronary heart disease and its preparation technology |
| 10/24/2007 | CN101057878A Pomegranate rind extraction and its preparation method |
| 10/24/2007 | CN101057863A Medicine for changing blood quality, preparation method and application |
| 10/24/2007 | CN101057859A Depolymerization glycosaminoglycan extracted from sea cucumber composition and its preparation method and application |